Cipla USA, Inc. Fosfomycin Tromethamine Granules for Oral Solution recall: Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
The hazard: Potency, impurity or stability failure
The recall concerns the strength or purity of the medicine rather than contamination of it, which changes what you should do about a dose you have already taken.
What the notice says: Failed Impurities/Degradation Specifications
Why it matters: The product failed a specification test: it may contain more or less active ingredient than the label states, carry an impurity, or degrade before its expiry date. A sub-potent dose can leave a condition untreated; a super-potent one can cause an overdose.
Symptoms and when to call a doctor
The risk depends entirely on the drug. For a medicine where dose matters closely — a blood thinner, an anti-epileptic, a thyroid or heart medicine, insulin — talk to your prescriber before changing anything. Seek urgent care if you have symptoms that suggest too much drug, or if the condition the medicine controls starts breaking through.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0014-2027
- Published
- October 14, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Cipla USA, Inc.
- Product type
- Prescription & OTC drugs
- Units affected
- N/A
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot#: 5KA0405, Exp 12/31/2026.
Products covered by this recall
Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by: Cipla Ltd., Kurkumbh-413802, Maharashtra, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-579-67.
Check your product
The notice names 9 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- 5KA0405
- Exp 12
- 31
- 2026. — N
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 12
- 31
- 2026. — N
NDC number
On the carton and again on the bottle or blister label.
- 69097-579-67
Package size
Match the net weight or the piece count on the front of the pack.
- 3 Grams
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Potency
Cipla USA, Inc. — The recall concerns the strength or purity of the medicine rather than contamination of it, which changes what you should do about a dose you have already taken.
- Check the lot number on your pack against the codes listed above before you do anything else.
- Do not stop a prescription on your own. For most conditions an uncertain dose is safer than no dose while you get advice.
- Call your prescriber or pharmacist and ask whether to swap the lot, re-test, or change nothing.
- Keep the carton and the leaflet — the lot number is usually printed only on the outer pack.
Getting a replacement supply
Do not let a refund question interrupt your treatment. Deal with the supply first and the money second.
- Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
- Insurers do not normally count a recall replacement against a refill limit. If one is refused, ask the pharmacist to call it through as a recall override.
- Over-the-counter products are refunded at the till like any other purchase; the recall notice on your phone is enough to explain the return.
- If the manufacturer runs a direct reimbursement form, it will be linked from the official notice on this page.
Company contact: Cipla USA, Inc. — 10 Independence Blvd, Warren, NJ, 07059-2730
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Cipla USA, Inc. prescription & otc drugs recalled?
Failed Impurities/Degradation Specifications Failed Impurities/Degradation Specifications
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code 5KA0405, Exp 12, 31; best-by date 12 or 31. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Check the lot number on your pack against the codes listed above before you do anything else.
Can I get my money back?
Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 4 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle recall: cGMP Deviations: presence of N-nitroso-cinacalcet
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
-
Class II · 4 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle recall: cGMP Deviations: presence of N-nitroso-cinacalcet
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
-
Class II · 4 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle recall: cGMP Deviations: presence of N-nitroso-cinacalcet
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
-
Class II · 6 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle recall: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
-
Class II · 6 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle recall: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
-
Class II · 6 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle recall: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit